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Abstract 
  This paper presents a test of the predictive validity of various classes of QALY 
models (i.e., linear, power and exponential models). We first estimated TTO utilities for 
43 EQ-5D chronic health states and next these states were embedded in health profiles. 
The chronic TTO utilities were then used to predict the responses to TTO questions 
with health profiles. We find that the power QALY model clearly outperforms linear and 
exponential QALY models. Optimal power coefficient is 0.65. Our results suggest that 
TTO-based QALY calculations may be biased. This bias can be avoided using a power 
QALY model.  
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Introduction  
It is current practice in economic evaluation of health care programs to use 
quality-adjusted life years (QALYs) as a measure of the utility of health outcomes. A 
QALY is basically a weighting scheme in which each period of life duration (e.g., years 
or a fraction of a year) is adjusted by the health state in which it is spent. According to 
this definition what is essential to QALYs is that life duration and health status are 
separable. Due to this reason some authors refer to basic classes of QALY models as 
multiplicative utility models (e.g., Miyamoto and Eraker, 1988; Miyamoto, 1999). That 
is, QALY models in which duration and health status are combined in a multiplicative 
way. Formally, if (Q, T) denotes a chronic health state, where Q stands for constant 
health status throughout T periods of time until dead, then the multiplicative QALY 
model asserts that  
 
U(Q, T) = H(Q) ⋅ G(T),          ( 1 )  
where H and G are utility functions over health status and duration, respectively. It is 
further assumed that G(⋅) is increasing in duration and G(0) = 0.  
However, whenever publications refer to the QALY model, authors usually 
mean the linear QALY model, that is, the specific multiplicative utility model 
characterized by assuming that the utility of the life duration is linear. Despite of 
QALYs are often discounted for practical proposes the linear QALY model remains as 
the simplest and most widely used QALY model. If G(T) is equal to T in Equation 1, 
then we obtain the linear QALY model  
U(Q, T) = H(Q) ⋅ T,         ( 2 )  
As various researchers have remarked (e.g., Wakker, 1993; Miyamoto, 2000) the 
linear QALY model greatly simplifies utility calculations, because fewer measurements   3
are needed to calculate the utilities of sequences of health states (henceforth: health 
profiles). Once the validity of the linear QALY model is assumed, practitioners only 
need to estimate utilities for chronic health states, and then by assuming that the utility 
of the health profile is additive over separate (or disjoint) time periods (i.e., each period 
during which health status does not vary) the number of QALYs follows. Of course, the 
utility of health profiles can be also computed in a similar way by using non-linear 
QALY models (e.g., Miyamoto, 1999), but it requires as an additional task to fit some 
parametric utility function for duration to data (e.g., Miyamoto and Eraker, 1985; 
Sttigelbout et al., 1994) or, alternatively, to apply a group estimate of the parameter that 
is regarded as a good approximation (e.g., Miyamoto, 2000).  
Let us to explain how Equations (1) and (2) can be extended to health profiles. 
Let (Q1, T1; Q2, T2) stand for a health profile where state Q1 lasts for T1 periods, and 
state Q2 lasts for T2 periods, followed by death. Next, for simplicity, assume that both 
Q1 and Q2 are better-than-death health states (i.e., states in which longer duration is 
preferred to shorter duration) and also assume that G(.) is concave. Figure 1 (bottom) 
shows concave utility functions for life duration in chronic health states Q1 and Q2. To 
apply Equation 1 to (Q1, T1; Q2, T2) we have to assume that U(Q1, T1; Q2, T2) is additive 
over separate periods T1 and T2. Under this assumption, the upper part of Figure 1 
shows how the segments of the chronic health state utility functions are combined by 
adding the utility increments H(Q1) ⋅ {G(T1) – G(0)} and H(Q2) ⋅ {G(T1 + T2) - G(T1)} 
during the separate periods T1 and T2. The height of the point a denotes the utility of 
H(Q1) ⋅ G(T1), since G(0) = 0. The height of the point b denotes the overall utility of the 
health profile computed as the sum of the abovementioned utility increments. Hence, 
under the additivity assumption, the multiplicative QALY model (2) implies that   
   4
U(Q1, T1; Q2, T2) = H(Q1) ⋅ G(T1) + H(Q2) ⋅ {G(T1 + T2) - G(T1)}    (3) 
 
If we extent this example to the more general case of n-tuples (Q1, T1; Q2, T2; ...; 
Qn, Tn) where duration ranges from 1 to n time periods, the multiplicative QALY model 
will be defined by (Miyamoto, 1999: p. 206, Eq. 6):   
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We note that although Equation (4) may look complicated, it simply describes 
algebraically the normal process of construction of the utility of a health profile when 
the utility function for duration is not linear. For example, suppose that we want 
computing the utility of health profile (Q1, 3 yrs; Q2, 5 yrs) and we discount each year 
by applying a non-linear utility function. We can then elicit H(Q1) and H(Q2) and then 
computing the utility of the entire profile as H(Q1) ⋅ G(1) + H(Q1) ⋅G(2) + H(Q1) ⋅G(3) + 
H(Q2) ⋅ G(4)+ …+ H(Q2) ⋅ G(8), where 1 stands for “first year”, 2 stands for “second 
year” and so on. Alternatively, we can compute the utility of the profile according to 
Equation (4), that is, H(A) ⋅G(3) + H(B) ⋅{G(8) – G(3)}, where 3 and 8 denote three and 
eight years respectively. As it is easy of checking, both ways of calculating QALYs are 
equivalent.  
It is straightforward that if we apply the linear QALY model (1) to any arbitrary 
health profile then Equation (4) is reduced to the standard formula   





t t T Q H       (5) 
In sum, Equations (1) and (5) characterize the linear QALY model, whereas 
Equations (2) and (4) characterize the multiplicative QALY model.    5
Empirical evidence on the validity of the linear QALY model is mixed. Most 
empirical tests of the assumptions underlying the linear QALY model for chronic health 
states have generally yielded negative results (e.g., McNeil et al. 1978; Pliskin et al. 
1980; Miyamoto and Eraker 1985; Stiggelbout et al. 1994; Verhoef et al. 1994; Wakker 
and Deneffe 1996; Stalmeier and Bezembinder 1999). In particular, evidence available 
hitherto supports that the utility function for duration is concave rather than linear 
(Dolan, 2000).   
However, the majority of the previous tests were performed within the realm of 
Expected Utility (EU). The exceptions are the tests performed by Bleichrodt and Pinto 
(2001) and Doctor et al. (2003). Whereas the former rejected the linear QALY model 
within a framework consistent with Rank-Dependent Utility (RDU), the latter found 
considerable support for the linear QALY model within a more general framework 
compatible even with Prospect Theory (PT). Hence, as Doctor et al. argue, it is possible 
that the observed violations of the linear QALY model might have been caused by 
violations of EU.  
 Empirical tests of the linear QALY model for health profiles are not conclusive 
either. Treadwell (1998) and Spencer (2001) found empirical support for the assumption 
of additivity over time periods. However, evidence on sequencing and discounting 
effects (e.g., Krabbe and Bonsel 1998; MacKeigan et al. 2002) challenges the validity of 
the linear QALY model.  
This study aims to test the validity of the linear QALY model in a different way 
from that typically followed in most previous empirical studies. Instead of testing any 
critical assumption to the linear model we perform a test of its predictive validity. With 
predictive validity we mean to test whether preferences over health profiles can be 
accurately predicted from utilities for chronic health states. This approach has the   6
advantage that it does not depend on a specific utility framework (e.g., EU or PT), 
because we are testing a prediction common to any multiplicative QALY model.  
Although there are some other studies that have also tested predictions of the 
linear QALY model they have followed a different approach. Most predictive tests have 
compared the number of QALYs yielded by a health profile to some sort of holistic 
assessment for the same profile. These studies have generally found large discrepancies 
between QALYs and holistic assessments (e.g., Richardson et al., 1989; Lipscomb, 
1989; Kupperman et al., 1997). However, discrepancies can only interpreted as failures 
of the linear QALY model as long as holistic assessments are accepted as a norm or 
gold standard.   
In this respect, our approach is closer to that followed by Bleichrodt and 
Johannesson (1997) and Bleichrodt et al. (1999). Bleichrodt and Johannesson compared 
the predictive validity of three elicitation methods (Standard Gamble, Time Trade-Off, 
and Visual Analogue Scale) under EU both for linear and discounted QALY models. 
Predictive validity was assessed by testing the degree of association between direct and 
predicted rankings of health profiles. Bleichrodt and Johannesson found that the 
combination of TTO utilities and a null discount rate had the highest predictive validity. 
In a similar way, Bleichrodt et al. (1999) tested the validity of the SG method with and 
without rank-dependent weighting. They also examined linear/exponential and 
log/power families of utility functions for duration. They found that utility curvature 
improved the predictions of the multiplicative QALY model.  
This study also try to go beyond simply testing the performance of the linear 
QALY model. We try to shed some light on each of four related questions, namely: 
 
a. Which is the non-linear QALY model with a higher predictive validity.   7
 
We test the predictive validity of two non-linear QALY models, namely: the 
power QALY model and the exponential QALY model. We have chose these two models 
because they have been frequently used in axiomatic work on QALYs both under EU 
(e.g., Pliskin et al., 1980; Miyamoto et al., 1998; Miyamoto, 1999) and non-expected 
utility (e.g., Miyamoto, 1988; Miyamoto and Eraker, 1988; Bleichrodt and Pinto, 2001). 
Also, power and exponential specifications have been widely employed in medical 
decision analysis (e.g., Pauker, 1976; Mass and Wakker, 1994; Cher et al., 1997; 
Enemark et al., 1998). We will choose as the better QALY model that one with higher 
predictive validity. To that end we will estimate the parameter values that most 
improves the predictive validity of the two non-linear QALY models selected.  
Bleichrodt et al. (1999) also tested the predictive validity of the power and 
exponential models, but they did not estimate the optimal parameters of these models. 
They gave different values to power and exponential parameters and selected the value 
that better predicted preferences.  
 
b. The influence of utility curvature on a wide range of health states. 
 
It has not been tested if the potential improvement of the non-linear over the 
linear QALY model is constant for all degrees of severity. To test this we use a set of  
43 EQ-5D health states. Bleichrodt et al. (1999) only used two health states (i.e., full 
health and an intermediate health state). In other papers researchers used three health 
states at best (e.g., Richardson et al., 1996; McKeigan et al., 1999; Bleichrodt and Pinto, 
2001). 
   8
c. The influence of utility curvature on Time Trade-Off utilities. 
 
 The elicitation method selected to perform our test is the TTO. We choose this 
method because there is some evidence that the TTO is more consistent with individual 
preferences than the SG (e.g., Dolan et al., 1996; Dolan, 2000). Indeed, as noted above, 
Bleichrodt and Johannesson (1997) found that the TTO without discounting yielded the 
highest predictive validity. However, it is also true that various researchers have warned 
about the risk that TTO utilities are biased downwards if utility for duration is concave 
(e.g., Miyamoto and Eraker, 1985; Johannesson et al., 1994; Dolan and Jones-Lee, 
1997). In consequence, we think that it is important to examine the influence of utility 
curvature over the consistency of TTO utilities. For example, if TTO utilities were 
biased by utility curvature the widely employed EuroQol algorithm (TTO-based) might 
be also biased, leading to wrong allocations of health resources. 
 
d. The structure of preferences on a wide sample of the general population. 
 
Most of previous empirical papers were based on small convenience samples 
(e.g., Dolan and Gudex, 1995; Kupperman et al., 1997; MacKeigan et al., 1999). 
However, it is a common view in Cost-Effectiveness Analysis (CEA) that health state 
utilities should be collected from a representative sample of general population (Gold et 
al. 1996). We think that it is very important for policy decisions to check if the potential 
superiority of the non-linear over the linear QALY model also holds when a 
representative sample of the general population is used. In consequence, we elicit 
preferences from a relatively large sample (nearly 1,300 people) of the general 
(Spanish) population.    9
The paper is structured as follows. In Section 2 we describe the test of the linear 
QALY model that we are going to perform. In a first survey, we estimate TTO utilities 
for 43 health states described to the respondents as chronic conditions. Next, in a second 
survey, the same collection of health states are embedded in health profiles which 
combine the specified health state with full health. The TTO utilities estimated in a first 
survey are then used to predict the responses to TTO questions used in the second 
survey. We emphasize that respondents were randomly drawn from a single population. 
Hence, our null hypothesis assumes that, up to sampling error, the linear QALY model 
leads to the right prediction. This implies that no significant difference is found between 
predicted and observed responses. Otherwise, if the null hypothesis is rejected we 
would next examine whether two alternative single-parametric utility specifications 
(i.e., power and exponential models) improve the prediction. This alternative hypothesis 
is described in Section 3. In Section 4 we present the study design and the statistical 
methods to be used. Section 5 shows the results. Conclusion closes the paper.  
 
2. Predictive validity of QALYs  
 
First, assume that the set of chronic health states may contain both better-than-
death and worse-than-death  states. Next, assume that the linear QALY model (2) 
represents the individual’s true preferences over the overall set of chronic health states. 
We note that the existence of better-than-death and worse-than-death health states is not 
in conflict with the linear QALY model (nor with the multiplicative QALY model). In 
fact, as various authors have emphasized (e.g., Miyamoto and Eraker, 1988; Miyamoto 
et al., 1998; Miyamoto, 1999) the existence of better-than-death and worse-than-death 
states is a diagnostic of a multiplicative relationship.      10
Assume now that the TTO is used to elicit the utility of health states Q
I and Q
W 
defined as chronic conditions (Torrance, 1986). Assume that if any of the health states 
was regarded as worse than death its TTO utility would be set equal to – Y/(T – Y), 
where T denotes the duration in the state Q
I and Y stands for the duration in Full Health 
(FH). Hence, we do not rescale negative utilities so that they range from -1 to 1. This is 
an arbitrary transformation after which valuations cannot longer interpreted as true 
utilities (Patrick et al., 1994).  
Next, assume that we have two health profiles such as (FH1, T1; 
W Q2 , T2; FH3, 
T3) and (
I Q1 , T1 ; 
I Q2 , T2; FH, T3) followed by death, where Ti denotes duration. Since 
health state Q
I is the same during periods T1 and T2, we can represent the profiles as 
(FH1, T1; Q
W, T2; FH3, T3) and (Q
I, T1+2; FH3, T3) where T1+2 stands for T1 +T2. Finally, 
assume that the linear QALY model (5) describes correctly the preferences over health 
profiles and that the individual is indifferent between the two profiles. Let H(FH) =1 
and H(death) =0. Then Equation (5) yields  
 
T1 + H(Q
W) ⋅ T2 = H(Q
I) ⋅ T1+2        ( 6 )  
 
   One way of testing the predictive validity of the linear QALY model is fixing 
two of the three durations (i.e., T1, T2, T1+2) and eliciting the third one. The elicited Ti 
should coincide with the estimate (denoted by i T ˆ ) we get from Equation (6). Thus the 
null hypothesis of the test asserts that there is no significant difference between 
predicted and observed durations. On the contrary, our alternative hypothesis asserts 
that non-linear QALY models will describe preferences better than the linear one. If 
non-linear QALY models outperformed the linear one we would expect that taking into 
account utility curvature could partly remove the discrepancy between predictions and   11
actual data. Indeed, as noted in introduction, various authors have proposed previously 
to adjust TTO measurements for utility curvature. Hence, if our test rejects the linear 
QALY model, we will then test the degree of improvement in predictive validity of the 
power and exponential QALY models. The better they describe preferences the lower 
the difference between  i T ˆ  and Ti. 
 
3. Power and exponential QALY models  
  
We will compare two classes of non-linear QALY models, namely: the 
exponential QALY model and the power QALY model
1. In both cases the utility function 
over duration is described by a single parameter λ. The power specification implies that 
proportional time tradeoffs are constant (Pliskin et al., 1980) and, under EU, the power 
parameter may encapsulate attitude towards risk, time preference, and diminishing 
marginal value (Gafni and Torrance, 1984).  
The exponential function satisfies constant absolute (rather than proportional) 
tradeoffs (Happich, 2001) and it reduces to the constant discounting model if time is 
discrete. Derivations of TTO utilities after adjusting by utility curvature are provided in 
Appendix 1. 
 
CASE 1. The exponential QALY model asserts that: 
U(Q, T) =  () e 1 k ) Q ( H
ư − − ⋅          ( 7 )  
                                        
1 See Miyamoto (1999) for a characterization of these models under EU and under RDU assumptions. 
Bleichrodt and Miyamoto (2002) present axiomatizations for these models under Cumulative Prospect 
Theory.   12
where coefficient k is a scaling constant equal to
) e (1
* T
T* λ − −
and T* is the maximum 
lifetime duration in the given domain. Within the range from 0 to T*, the exponential 
function k ⋅ (1-e
-λT) can be concave (λ > 0) as well as convex (λ < 0).  
If we assume the validity of the exponential QALY model (7), under the 
assumption of additivity over disjoint time periods, Equation (6) changes into 




1 1 + ⋅ = − − ⋅ + −
λ −
+
λ −           (8) 
where asterisk * denotes that TTO utility H has been adjusted by λ.  
 
CASE 2. The power QALY model asserts that:   
U(Q, T) =  () T k   Q H
λ ⋅         (9) 
where k is a scaling constant equal to 
() * T
* T
λ  and T* is the longest duration in the given 
domain. Within the range from 0 to T*, the power function kT
λ can be concave (λ < 1) 
as well as convex (λ > 1).  
If we assume the validity of the power QALY model (9), under the assumption of  
additivity over disjoint time periods, Equation (6)changes into 
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We conducted two surveys in order to perform the test. In a first survey, 43 EQ-
5D health states were valued as chronic conditions by 977 respondents (sample 1). In a 
second survey, 300 respondents (sample 2) the same health states were embedded in   13
different health profiles. 
The surveys were carried out by 11 interviewers over a 6-month period, 
following a 2-day training period. The two groups of respondents were randomly 
selected from Spanish general population. Age and gender quotas were used to ensure 
representativeness on these parameters according to the 1991 Spanish census. Potential 
respondents were contacted initially by letter, and then by follow up telephone calls.  
Respondents who were unable to read or write, or who were cognitively 
impaired (according to the Pfeiffer test), or who had a severe illness or mental disorder, 
were replaced by others in the same sex-age quota. Background data, health 
expectations, and opinions regarding the interview were collected at the end of the 
interview. 
 
- Health states 
The subset of EQ-5D health states selected is the same that Dolan (1997) used to 
model the EuroQol algorithm. In the first survey, each respondent assessed a random 
selection of 13 health states including 2 very mild states, 3 mild states, 3 moderate 
states, 3 severe states, and the states ‘11111’ (i.e., full health) and '33333'. In the second 
survey, respondents did not value states ‘11111’ and '33333' because of they were used 
as reference health states.  
[Insert Table 1 about here] 
 
- Elicitation procedure 
Respondents belonging to sample 1 first described and rated their own health 
state using the EQ-5D descriptive system and the VAS method with endpoints 0 –100 
of worst and best imaginable health state respectively. They then ranked their selection   14
of 13 health states (plus unconsciousness, but excluding ‘death’) in order of preference. 
Respondents were asked to imagine that each health state would last for 10 years 
without change, followed by death. After they ranked the health states, they were asked 
to rank ‘death’ among those states, and were given the option at this point of reordering 
their previous ranking.  
Utilities were elicited by means of the TTO method for chronic health states 
(Torrance, 1986). For health states regarded as better than death, we asked for the 
duration Y that yields indifference between surviving 10 years in the target health state 
and surviving Y years in health state ‘11111’. For states regarded as worse than death, 
we asked for the duration Y that leads to the indifference between dead and surviving 
(10- Y) years in the target state followed by Y years in ‘11111’. The order in which 
each respondent ranked and valued his/her selection was randomized to avoid anchoring 
and adjustment biases.   
Respondents belonging to sample 2 first ranked their selection of 13 health states 
plus death and unconsciousness. Then they were asked two compare two health profiles 
such as (FH, T1; 33333, T2; FH, T3) and (Q
I, T1+2; FH, T3) both followed by death. It 
was set that T1 + T2 = T1+2 = 12 months, and T3 = 9 years. We then elicited T1 and 
compared it with  1 T ˆ  obtained using Equation (6), that is 
 
1 T ˆ    = 
) 33333 ( H 1




x 12      ( 1 1 )  
 
Empirical evidence supports that preferences inferred from choices are more 
consistent than preferences inferred from matching or judgments of selling prices (e.g., 
Bostic et al., 1990). In this way, all chronic health states and health profiles were   15
presented to respondents as choices. Indifference points in both samples were stated at a 
level of proportions of months in order to ensure that precision in responses were 
similar across samples. For example, questions with health profiles were first presented 
as a choice between a profile with 6 months in health state ‘11111’ and 6 months in 
state ‘33333’ followed by 9 years in ‘11111’ and a profile with 12 months in the target 
health state followed by 9 years in ‘11111’ as well. After the choice was described 
respondents were asked whether they preferred the first or the second profile, or 
whether they were indifferent between both. In case the respondent preferred either the 
first or the second health profile, the interviewer next varied duration in health states 
'11111' and '33333' until indifference was reached. Throughout this choice-bracketing 
exercise respondents were allowed to revise earlier answers and, in order to avoid 
response errors, they were asked to confirm the elicited indifference values.    
 
- Estimation methods 
Differences between predicted and observed durations obtained under the linear 
QALY model are tested by the two-sample t test. If significant differences were found, 
we would then estimate the optimal value (i.e.,λ ˆ ) of power and exponential coefficients 
of the QALY models described in Section 3.   
The procedure we would employ in order to estimate the optimal coefficients 
would be an optimization algorithm based on the Newton-Raphson method (Greene, 
1999). We remark that this procedure is not a regression analysis. In the context of this 
study, goodness of fit means minimizing the differences between responses constructed 
from sample 1 and observed responses from sample 2.  
The specific procedure is as follows. We start setting a utility function for 
duration with λ =0 in the exponential model, and with λ =1 in the power model. That is,   16
we fix a linear utility function. Next, by varying λ for each respondent in sample 1, we 
obtain a value of the parameter such that is minimized the sum of squares over the 
differences between the mean predicted responses  i T ˆ  and the mean observed responses 
T i
_
 across 41 EQ-5D health states
2. Therefore, the objective function to be used in 
estimations (see below, Equation 12) would be a summary obtained from individual 
data. As Miyamoto (2000) has argued, the aggregation across responses in order to yield 
the fit may be a more accurate representation of preference than are the individual data 
because the individual points almost always exhibit greater random variation than a 
summary constructed from the data. From this perspective, since the responses to any 
elicitation method (and the TTO is not an exception) are not free from random variation, 
the overall minimization of differences across responses and health states may be one 
way to obtain a more accurate approximation to true preferences.  
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ij i T ˆ
J
1
T ˆ , where subscript i denotes the health state and subscript j 
denotes the respondent belonging to sample 1 valuing state i. 




Table 2 compares the sociodemographic characteristics of both samples. The 
two samples were very similar in terms of gender and age (Chi-square, P = 0.97 and 
                                        
2 Health states '11111' and '33333' were used as reference states in the questions with health profiles, so 
they were not included in estimations.   17
0.93 respectively), although there existed significant differences in educational and 
employment status (Chi-square, P < 0.01 in both comparisons). 
 
[Insert Table 2 about here] 
 
We excluded 54 subjects from the data analysis of the TTO utilities because they 
did not assign the lowest value to health state `33333´. Four participants in the second 
survey were also excluded from the data analysis because they did not want to make 
some tradeoffs. Hence, the final analysis is based on the responses of 923 and 296 
subjects, respectively. 
 
[Insert Table 3 about here] 
 
Table 3 shows that the null hypothesis cannot be rejected for 7 of the 41 states 
displayed (they have been ranked in increasing severity order according to chronic 
utilities). Thus, differences between  i T ˆ   and T i
_
are statistically significant for almost all 
health states. The largest differences were found for severe states. The maximum 
difference (= 3.399, i.e., three months and twelve days) was observed for the worse-
than-death state '13332’.  
It is noticeable that  i T ˆ  was lower than T i
_
 for the majority of the states. Only for 
three very mild states there is a positive difference and it was not statistically significant 
in two of them. Moreover, differences increase with severity, although there are 
variations in the final part of the domain of the health states.    18
The discrepancy between  i T ˆ   and T i
_
 was minimized under exponential and 
power models for λ ˆ = 0.48 and 0.65 respectively. These estimates imply a concave-
shaped utility function for duration.  
 [Insert Figure 2 about here] 
Figure 2 displays clearly that the power QALY model outperforms the rest. 
Under this model differences were not significant in 32 out of the 41 health states used 
in the comparison. In those health states where differences were greater than zero they 





The main findings and implications derived from the present study are 
summarized as follows: 
1.  We find significant differences for almost all the health states under the 
linear QALY model. This result suggests that the linear model is not a good 
descriptive model.  
2.  It seems that the linear QALY model is most likely to hold for mild health 
states. It is for severe health states when the deviation seems larger. This 
result is consistent with other findings reported elsewhere in the literature 
(e.g., Sutherland et al., 1982; Kirsch and McGuire, 2000).  
3. The  power QALY model had the highest predictive validity. It removed 
differences between observed and predicted responses for the majority of 
health states (around 80%). This functional form has been frequently used in 
the decision-theory literature (e.g., Tversky and Kahneman, 1992) and it has 
been also proposed as a good instrument for medical decision analysis (e.g.,   19
Stiggelbout et al., 1994; Bleichrodt and Pinto, 2000). In addition, and 
opposite to exponential models, the power model satisfies that TTO 
measurements remain constant with independence of the reference duration 
fixed throughout the assessment task (Pliskin et al., 1980).  
4.  The parameter estimated (λ ˆ =0.65) indicates that the shape of the utility 
function for life duration is concave rather than linear. Under EU concavity 
of the utility function for duration can reflect risk aversion, positive time 
preference and diminishing marginal value (Gafni and Torrance, 1984). 
Under other non-EU theories, like rank-dependent utility, concavity would 
just display time preference and diminishing marginal utility because risk 
attitude is reflected in the probability weighting function (Wakker, 1994). 
Since TTO measurements are riskless, in our study concavity cannot be 
interpreted under EU as reflecting risk aversion. Hence that concavity just 
displays ‘time’ and ‘quantity’ effects. Obviously, as the magnitude of the 
lifetime duration is confounded with the timing of the health outcomes, 
separating time preference from quantity effects is problematic (e.g., 
Chapman, 1997).  
5.  The finding of concavity is in line with those empirical studies that estimated 
the utility function by a power function (e.g., Miyamoto and Eraker, 1985; 
Stiggelbout et al., 1994; Bleichrodt and Pinto, 2000; Bleichrodt and Pinto 
,2001). We note, however, that our parameter has a value somewhat lower 
than previous studies (reported mean λ  ranges from 0.74 to 1.03). 
Nevertheless, we emphasize that those studies are different from ours. First, 
previous studies used one or, at best, three health states while we have used 
43 different health states. Second, we have also used a larger sample-size and   20
estimated a summary parameter from individual data adjusting 
simultaneously all the health states. Lastly, experiments conducted by 
Bleichrodt and Pinto tested the power function under nonexpected utility, in 
which case it was expected a lower curvature (i.e., a higher value). 
6.  Discounting is a standard practice in economic evaluation of health care. 
However, our results cast doubt on the conventional approach of applying an 
exponential factor in order to discount TTO-based QALYs. We find that the 
exponential model works only slightly better than the linear model. Indeed, 
the discrepancy between predictions and observed data remains quite large 
(it only vanishes for ten health states) even after TTO utilities are adjusted by 
utility curvature as Johannesson et al. (1994) recommended. Our finding is 
similar to results reported by MacKeigan et al. (2002). They also adjusted 
TTO utilities, and found a large difference between discounted TTO-based 
QALYs and holistic utilities.  
7.  TTO utilities estimated under linearity may be biased. This implies that the 
EuroQol algorithm, which is based on conventional TTO valuations, may 
lead to wrong allocation of resources. We have obtained empirical support 
for adjusting TTO utilities by concavity in order to correct the utility 
curvature bias. However, Bleichrodt et al. (2002) find some indication that 
the downward bias in the TTO utility caused by utility curvature 
approximately offsets other upwards biases (e.g., loss aversion), so the TTO 
is consistent for longer reference durations than that we have used here (i.e., 
10 years). This may explain that the TTO was the best method in the study 
conducted by Bleichrodt and Johannesson (1997). In that study, the reference 
duration used in TTO measurements was set equal to 30 years. Thus, we   21
cannot reject the possibility that the different biases in the TTO cancel out 
for long temporal horizons. Further investigation is needed to identify the 
specific domains in which conventional TTO measurements may be 
acceptable. 
Our paper has, at least, three limitations. First, we have used and inter-rater test. 
In some respect, this avoids anchoring effects and guarantees that the results at the 
aggregate level are consistent. However, we cannot estimate the degree of validity of 
the non-linear QALY model at the individual level as Bleichrodt et al. (1999) did. 
Further research is needed in order to study this question. Second, despite the use of a 
very similar methodology in the two surveys, the two samples varied in terms of 
educational and employment status. Both factors may potentially affect health state 
valuations (Badía et al., 1995). Lastly, the health profiles that are compared in our test 
only differ in the first year. Hence, it would be interesting to reply our test using larger 
durations. This question should be address in future investigations.  
Our results seem to support that TTO utilities are estimated according to a non-
linear (power) QALY model. In principle, it seems that the best estimate is around 0.65. 
This value is not very different from previous findings where values range from 0.74 to 
0.8. In some respect, given the size and representativeness of the sample, and the 
number of health states evaluated, it seems that our estimate is a good candidate in 
practical decision making. We believe that for cost-effectiveness studies TTO utilities 
should be adjusted using a power function for duration.   22
Appendix 1: Elaboration of TTO utilities adjusted for utility curvature 
 
CASE 1. Elaboration of the adjusted TTO utility under the exponential QALY model: 
If health state Q is regarded as better than death, then substituting the 
exponential QALY model in the indifference between (Qi, T1) and (FH, T2) reached by 

















         [ A 1 ]  
If  Qi is regarded worse than death, then substituting the exponential QALY 
model in the indifference between (Qi, T1–T2; FH, T2) and dead reached by means of the 



























          [ A 2 ]  
CASE 2. Elaboration of the adjusted TTO utility under the power QALY model: 
If health state Qi is regarded as better than death, then substituting the power 
QALY model in the indifference between (Qi, T1) and (FH, T2) reached by means of the 
TTO method, we have  
 













2          [ A 3 ]  
If Qi is regarded worse than death, then substituting the power QALY model in 
the indifference between (Qi, T1–T2; FH, T2)  and dead reached by means of the TTO 
method, we have    23
 
  H*(Qi) = -  ()( )
() T - T
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Figures and tables 
Figure 1. Assessment of health profiles under the non-linear QALY model 
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Figure 2. Differences under linear and non-linear QALY models 
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Table1. Health states 










































Note: health states ‘11111’ and ‘33333’ were also used.  
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   Table 2. Sociodemographic characteristics 




Gender     
Female  535 (54.8%)  164 (54.7%) 
Male   442 (45.2%)  136 (45.3%) 







    
Educational level    
No formal studies  149 (15.2%)  65 (21.7%) 
Elementary  570 (58.3%)  184 (61.2%) 
Secondary  140 (14.3%)  38 (12.8%) 
Universitary  119 (12.2%)  13 (4.3%) 
    
Employment status    
Employed  406 (41.6%)  121 (40.3%) 
Unemployed  103 (10.5%)  14 (4.6%) 
Housewife  193 (19.8%)  95 (31.7%) 
Retired  143 (14.6%)  32 (10.7%) 
Student  77 (7.9%)  28 (9.3%) 
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Table 3. Difference between  i T ˆ   and  T i
_


















λ λ λ λ = 0.65 
11121 0.135  -0.214  -0.108 
11112 0.162*  -0.296  -0.087 
21111 0.136  -0.311  -0.083 
11211 -0.235  -0.398  -0.095 
12111 -0.425  -0.345  -0.071 
11122 -0.009*  -0.381*  -0.096 
12211 -0.446  -0.318  -0.124 
12121 -0.749**  -0.408*  -0.132 
12222 -0.570  -0.389*  -0.107 
22121 -0.834**  -0.451*  -0.118 
11113 -0.746**  -0.472 -0.127 
22112 -0.970**  -0.428 -0.148 
21222 -0.637*  -0.493  -0.129 
22122 -1.064**  -0.567 -0.183 
22222 -0.795**  -0.583**  -0.185* 
11312 -0.807*  -0.482**  -0.196 
11131 -1.559**  -0.509**  -0.202* 
21312 -0.975**  -0.528**  -0.248* 
12223 -1.794**  -0.561**  -0.195 
13311 -1.417**  -0.576**  -0.241 
21133 -0.889**  -0.527**  -0.174 
11133 -1.557**  -0.602**  -0.128 
21232 -1.856**  -0.542**  -0.167 
13212 -2.456**  -0.508**  -0.111 
21323 -1.385**  -0.631**  -0.184* 
23321 -2.349**  -0.627**  -0.198* 
32211 -1.158**  -0.608**  -0.214* 
23232 -2.116  -0.584**  -0.149 
22331 -2.142**  -0.596**  -0.127 
22323 -2.279*  -0.534**  -0.159 
22233 -2.241**  -0.589**  -0.085 
33212 -1.125**  -0.607**  -0.099 
23313 -2.565**  -0.599**  -0.148 
32223 -1.017*  -0.581**  -0.214* 
32313 -0.783**  -0.617**  -0.183 
13332 -3.399**  -0.624**  -0.194* 
32232 -1.345**  -0.574**  -0.296 
32331 -1.111**  -0.586**  -0.219* 
33321 -2.263**  -0.649**  -0.109 
33232 -2.572*  -0.614**  -0.158 
33323 -2.629**  -0.697**  -0.082 
* Differences significant at the 5% level. ** Differences significant at the 1% 
level 
 